Insight and evidence throughout the lifecycle from pre-launch scoping an initial understanding of market landscape through to determining the impact of new competitors or patent loss on a brand’s potential.
Adelphi Real World offer insights into all stages of the patient journey, from both patient and physician, from pre-diagnosis through to the patient’s status on the day of data collection. Our proven methodologies provide interlinked data across stakeholder groups to highlight key disconnects that could exist between patients and their treating physicians, but also areas where physicians’ attitudes or behaviour, are not reflected in their actions and prescribing patterns.
The evidence generated can be used to understand brand share and source of business, market dynamics, patient profiles and journeys, brand perceptions and placement, unmet therapeutic need, drivers and barriers to prescribing patient segmentation and overall market satisfaction. Evidence can be provided through one of our proprietary, multi-subscriber Disease Specific Programmes™ (DSPs) or a customized programme designed by our Bespoke team.